tirzepatide for obesity fda approval Wins Weight Loss BioCentury - Nov. 8 Quick

Challenges regarding GLP-1 agonists include anti-fibrosis, long-term tolerability, and regaining weight

But metformin isnt known for major weight-loss effects, and it can sometimes cause digestive issues

10.1111/j.1463-1326.2008.01016.x 82

miRNAs are known for their ability to modulate gene expression through target mRNA binding to control protein production or mRNA breakdown

Those caveats aside, however, the emergence of this new option, in particular to treating obesity, is attracting considerable interest among medical communities focused across the many different health conditions where overweight and other metabolic issues play a significant role